the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Inmate escapes Sri Aman prison weeks before scheduled release

Prisoner John Sambang Sangau escaped Sri Aman Central Prison through temporary gate while serving drug sentence, police launch manhunt.

SRI AMAN: A male inmate who was nearing the end of his sentence escaped from the Sri Aman Central Prison after climbing a temporary gate located behind one of the prison blocks at about 7.15 am today.

Sri Aman police chief, Supt Dennis Bunyam, said the prisoner, identified as John Sambang Sangau, 38, fled through an “Anti-Climb” project gate within the prison compound.

He said John had been serving his sentence under Section 15(1)(a) of the Dangerous Drugs Act 1952 since last Oct 20 and was scheduled for release on Jan 24 next year.

“Initial investigations revealed that the suspect escaped wearing only a pair of green long trousers,” he said in a statement.

The incident was detected by officers on duty, who immediately launched a search, but were unable to locate the suspect.

A police report was subsequently lodged by the prison at 8.34 am at the Sri Aman Police Station.

Following the escape, police have activated “Op Tutup”, setting up roadblocks at KM7 Jalan Sri Aman–Kuching, and mobilised personnel across all police stations in the district to implement “Op Kesan”.

“Assistance from the Sarawak Contingent Police Headquarters’ Tracker Dog Unit (K9) and the 23rd Battalion of the General Operations Force has also been requested to help track down the suspect,” he added. – Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings